We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BioShield II Patent Provision Under Fire From Drug Purchasers
BioShield II Patent Provision Under Fire From Drug Purchasers
October 18, 2005
A broad coalition of drug purchasers, insurance companies and trade associations is challenging a provision in a draft bioterrorism bill that would extend drug patents, arguing that the language would greatly increase costs by limiting the development of generic alternatives.